Anticoagulation in Non-Critically Ill Hospitalized Patients With COVID
The FREEDOM COVID Anticoagulation trial failed to demonstrate that therapeutic anticoagulation...
Read More
FDA / Research
COVI-PRONE trial on its back
The randomized COVI-PRONE clinical trial demonstrated no difference in the risk of endotracheal...
Read More
Covid Long Hauler Symptoms Reported by as Many as 1 in 7
Both severe and mild cases associated with symptoms months later Within three weeks of a...
Read More
Covid-19: Clotting Disorders Pause Roll-Out of Adenovirus Vaccines
Regulators in U.S. and Europe link vaccines to CVST and thrombocytopenia Several setbacks hampered...
Read More
Death Risk High in CLL Patients Infected with Covid-19
Risk is equally high for patients in ’watch and wait’ mode after prior treatment The...
Read More
Conference Highlights: IAS 2021
New research was presented at IAS 2021, the virtual 11th International AIDS Society Conference on...
Read More
Covid-19: 1-in-4 U.S. Hospital Deaths Linked to Caseload Surges
Close to 6,000 early pandemic deaths may have been avoided, NIH study found Roughly 1-in-4...
Read More
Covid-19: 1-in-3 Patients Reported Long-Hauler Symptoms
Lingering fatigue, loss of taste and smell reported most often Close to a third of people who...
Read More
Covid-19: CoronaVac Vaccine Highly Effective for Preventing Hospitalization, Death
Vaccine proved 66% effective for preventing disease in real-world study from Chile Real-world data...
Read MoreNew Research Finds J&J Vaccine Has Muscle Against Covid’s Delta Variant
The data is reassuring to people who got this shot.
Read More
Covid-19: HEPA Filters Plus Masks Substantially Reduce Viral Exposure
A viable solution for reducing Covid spread in close indoor settings? CDC researchers found that...
Read More
Covid-19: Breakthrough Infections Involve Lower Viral Load Following mRNA Vaccination
Vaccinated people less likely to infect others, study findings suggest Partial or full vaccination...
Read More
Covid-19: Protein-Based Vax Safe, Highly Effective, Study Finds
Efficacy similar to that reported for mRNA vaccines Peer-reviewed findings from a phase III trial...
Read More
Covid-19: mRNA Vaccines Convey Long-Lasting Protection, Study Finds
Booster doses may not be needed by many for years, or ever, findings suggest New research offers...
Read More
Covid 19: Thrombosis After mRNA Vax Rare, But Possible
Authors detail a case of thrombosis with thrombocytopenia after mRNA-1273 vaccination Although...
Read More
Covid-19: New Reports of Vaccine Linked Myocarditis
Most cases were in younger males, and most were mild Two case reports describe acute myocarditis...
Read More
Post-COVID-19 Symptoms Are Common, Affecting 23.2 Percent
MONDAY, June 28, 2021 (HealthDay News) — Post-COVID-19 conditions are common among patients...
Read More
Care Disparities Seen for COVID-19 Patients With, Without Schizophrenia
MONDAY, June 28, 2021 (HealthDay News) — There are disparities in health and health care...
Read More
Less Than 1 Percent of COVID-19 Patients Experience Reinfection
MONDAY, June 28, 2021 (HealthDay News) — Reinfection following COVID-19 is possible, but...
Read More
Covid-19: One Vax Dose Effective for Residents of Long Term Care Facilities
VIVALDI study finds 56% efficacy within 4-7 weeks Elderly residents of long-term care facilities...
Read More